Skip directly to Accessibility Notice

How to Purchase

Sign-up to Receive
Our Latest Insights

BBH
VanEck Vectors Biotech ETF

Fund Description

VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

 
 

  • Fund Ticker

    BBH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    Bank of New York Mellon
  • Index Ticker

    MVBBHTR
  • Index Rebalancing

    Quarterly

 
as of 05/17/19

  • 30-Day SEC Yield1

    0.36%
  • Total Net Assets

    $372.0M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.40%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Annual
  • Next Distribution Date

    12/20/2019

Portfolio Composition (%)
as of 05/17/19

  • % of Net Assets
  • Stocks

    99.95
  • Bonds

    0.00
  • Other

    0.00
  • Cash

    0.05

Daily Holdings (%) as of 05/17/19 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
Amgen Inc
AMGN US
179,866
30,561,032 8.22
Gilead Sciences Inc
GILD US
394,281
26,164,487 7.03
Celgene Corp
CELG US
239,601
22,862,727 6.15
Illumina Inc
ILMN US
65,706
20,213,137 5.43
Allergan Plc
AGN US
142,708
20,007,662 5.38
Exact Sciences Corp
EXAS US
206,396
19,853,231 5.34
Iqvia Holdings Inc
IQV US
140,986
18,845,599 5.07
Vertex Pharmaceuticals Inc
VRTX US
108,353
18,282,402 4.91
Alexion Pharmaceuticals Inc
ALXN US
134,697
17,631,837 4.74
Biomarin Pharmaceutical Inc
BMRN US
193,975
17,207,522 4.63
Incyte Corp
INCY US
211,845
16,354,434 4.40
Beigene Ltd
BGNE US
122,956
16,167,484 4.35
Sarepta Therapeutics Inc
SRPT US
121,318
14,760,761 3.97
Biogen Inc
BIIB US
61,717
14,150,474 3.80
Regeneron Pharmaceuticals Inc
REGN US
46,316
14,123,601 3.80
Qiagen Nv
QGEN US
375,597
13,923,381 3.74
Charles River Laboratories Internationa
CRL US
83,765
10,812,386 2.91
Grifols Sa
GRFS US
541,152
9,930,139 2.67
Neurocrine Biosciences Inc
NBIX US
110,208
8,709,738 2.34
Alnylam Pharmaceuticals Inc
ALNY US
121,355
8,196,317 2.20
Ionis Pharmaceuticals Inc
IONS US
118,546
7,990,000 2.15
Seattle Genetics Inc
SGEN US
106,967
7,104,748 1.91
Nektar Therapeutics
NKTR US
219,553
7,030,087 1.89
United Therapeutics Corp
UTHR US
70,740
6,412,581 1.72
Bluebird Bio Inc
BLUE US
35,301
4,530,530 1.22
Other/Cash
--
--
173,635 0.05
These are not recommendations to buy or to sell any security. Securities and holdings may vary.